Αποτελέσματα Αναζήτησης
Since January 2022, and as of 15th June 2022, a total of 2103 laboratory-confirmed cases of monkeypox, including one death, have been reported to the WHO from 42 countries in five of six WHO ...
Giovanni Battista Migliori 1 , Simon Tiberi 2 , Alimuddin Zumla 3 , Eskild Petersen 4 , Jeremiah Muhwa Chakaya 5 , Christian Wejse 6 , Marcela Muñoz Torrico 7 , Raquel Duarte 8 , Jan Willem Alffenaar 9 , H Simon Schaaf 10 , Ben J Marais 11 , Daniela Maria Cirillo 12 , Riccardo Alagna 13 , Adrian Rendon 14 , Emanuele Pontali 15 , Alberto ...
Our Seminar presents current perspectives on the scale of the epidemic, the pathogen and the host response, present and emerging methods for disease control (including diagnostics, drugs, biomarkers, and vaccines), and the ongoing challenge of tuberculosis control in adults in the 21st century.
After a rapid review of epidemiology and risk factors, the clinical priorities on MDR-TB diagnosis (including whole genome sequencing and drug-susceptibility testing interpretations) and treatment (treatment design and management, TB in children) are discussed.
Established by the UN in 2000, MDG target 6C was to halt and reverse tuberculosis incidence (defined as the number of new cases per 100 000 population per year).11 The Stop TB Partnership set two additional targets—to reduce tuberculosis prevalence and mortality by 50% by 2015, compared with numbers in 1990.
Professor Sir Alimuddin Zumla is professor of infectious diseases and international health at University College London. He is also a consultant infectious diseases at UCLH, honorary consultant at Royal Free Hospital, and holds a UK NIHR senior Investigator award.
Genetic analysis of drug-resistant MDR-TB showed that airborne transmission of undetected and untreated strains played a major role in disease outbreaks. The need for new TB vaccines and faster diagnos- tics, as well as the development of new drugs, has recently been highlighted.
